Prostate Cancer



ProstateCancerNews - 3/14/13
(MedPage Today) -- WASHINGTON, D.C. -- Medicare will pay for so-called FDG-PET scans for monitoring malignant tumors in routine practice, except in prostate cancer, according to a proposed decision memo. - 2/17/13
ORLANDO (MedPage Today) -- More than 90% of men with high-risk castration-resistant prostate cancer had significant biochemical responses to a novel anti-androgen, results of small clinical trial showed. - 2/15/13
ORLANDO (MedPage Today) -- Survival improved and disease progression slowed in men with metastatic castration-resistant prostate cancer treated in first line with abiraterone acetate (Zytiga). - 2/14/13
ORLANDO (MedPage Today) -- Immediate radiation therapy after radical prostatectomy led to a 50% increase in long-term biochemical progression-free survival for patients with locally advanced prostate cancer, according to a study reported here. - 2/14/13
ORLANDO (MedPage Today) -- Men with castration-resistant prostate cancer had worse survival when treated with corticosteroids, regardless of their primary treatment, a post-hoc analysis of a randomized trial showed.

Result Pages: 1 2 3 4 5 6 7 8 9 10 Next


Prostate Cancer Screening: The Scrutiny Continues
An international group of specialists propose a minimum age and PSA value to reduce overdiagnosis in prostate cancer screening. More »
Prostate Cancer: Radiotherapy and ADT Resistance
News of a possible strategy to avoid androgen deprivation therapy in prostate cancer, and clues to identifying those in whom resistance to ADT is likely to develop. More »
Prostate Cancer Therapy: Something Old, Something New
New guidance on treatment for high-risk prostate cancer, and a revelation about a new marker for prognosis. More »
Prostate Cancer: Look to the Lymph Nodes
Degeneration or apoptosis of metastatic prostate cancer cells in pelvic lymph nodes can distinguish between aggressive and non-aggressive disease, according to Minneapolis-based researchers. More »
Denosumab Most Effective in High-Risk Prostate Cancer Patients
The anti-RANKL antibody denosumab is more effective for preventing bone metastasis in men with high-risk castration-resistant prostate cancer compared with low-risk disease, according to results of a new study. More »
Showing 1 - 5 of 703 results.
Page of 141

PubMed - 2/28/13 - 2/14/13 - 2/14/13 - 2/14/13 - 1/31/13
More Results

ClinicalTrials - 1/17/13 - - - -
More Results

PracticeGuidelines - 8/31/10 - - - - -
More Results


Five Success Strategies for a Lean Medical Practice
Audrey "Christie" Mclaughlin, RN, January 23, 2014
How efficient practice managers keep clinics running smoothly.
Nine Questions to Ask Before Selling Your Practice to a Hospital
Aubrey Westgate,  January 22, 2014
Here are nine questions that can help reveal if becoming acquired by a larger system is the right move for you and your practice.
Four January Business Planning To-Dos for Doctors
Ike Devji, JD,  January 21, 2014
Here are some of the more important financial and business issues physicians should take care of this month.
Why Insurance Companies Should Collect Patient Payments
Leann DiDomenico McAllister,  January 20, 2014
It's time to take patient collections out of physicians' practices to truly have patients make responsible choices about their healthcare dollars.
How Facebook Helped Market a New Physician Practice Model
Raquel Baldelomar, January 17, 2014
An Arizona-based OB/GYN medical group found Facebook to be the most efficient and effective way to reach women and educate them on their new practice.


American Cancer Society
Prostate Cancer

National Cancer Institute
General Information About Prostate Cancer

National Comprehensive Cancer Network
Guidelines for Patients - Prostate Cancer